A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs ABT 981 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors AbbVie
- 19 Dec 2016 Status changed from active, no longer recruiting to completed.
- 16 Dec 2016 Trial has been completed in Denmark.
- 14 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.